Cancer Cachexia Market Share

Statistics for the 2023 & 2024 Cancer Cachexia market share, created by Mordor Intelligence™ Industry Reports. Cancer Cachexia share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Cancer Cachexia Industry

The cancer cachexia market is consolidated in nature due to the presence of very few major companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well known. Key market players include Aeterna Zentaris, Aphios Corporation, Bristol-Myers Squibb Company, Pfizer Inc., Helsinn Group, Merck KGaA, Artelo Biosciences Inc., NGM Biopharmaceuticals, Aveo Oncology, Aavogen Inc., Green Cross Wellbeing Corporation, Cannabics Pharmaceuticals Inc., TCI Peptide Therapeutics, Fresenius Kabi, Tetra Bio-Pharma, and Actimed Therapeutics among others.

Cancer Cachexia Market Leaders

  1. Merck & Co. Inc.

  2. Aphios Corporation

  3. Helsinn Group

  4. Bristol-Myers Squibb Company

  5. Pfizer

*Disclaimer: Major Players sorted in no particular order

Cancer Cachexia Market Concentration

Cancer Cachexia Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)